Wednesday, October 19, 2022

FDA Panel Recommends Pulling Preterm Birth Drug From the Market

The agency has weighed years of study that showed the treatment given accelerated approval 11 years ago was not effective.
http://dlvr.it/SbMVGK
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)